Evidence map›Paper›PMID 42897170›Full record

ArticleNature communications2026

Spatiotemporal metabolic networks in a preclinical model of pancreatic cancer and associated cachexia.

Blanca Majem, Min-Sik Lee, Kyung Cheul Shin, Insia Naqvi, Courtney Dennis, Lucas Dailey, Sarah Jeanfavre, Mari Mino-Kenudson, Joao B Xavier, Clary B Clish and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Blanca MajemDivision of Endocrinology, Boston Children's Hospital, Boston, MA, USA.
Min-Sik LeeDivision of Endocrinology, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0002-0563-8113
Kyung Cheul ShinDivision of Endocrinology, Boston Children's Hospital, Boston, MA, USA.
Insia NaqviDivision of Endocrinology, Boston Children's Hospital, Boston, MA, USA.
Courtney DennisMetabolomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Lucas DaileyMetabolomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0003-3204-9565
Sarah JeanfavreMetabolomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Mari Mino-KenudsonDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Joao B XavierComputational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-3592-1689
Clary B ClishMetabolomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0001-8259-9245
Deepti MathurDivision of Endocrinology, Boston Children's Hospital, Boston, MA, USA. mathur.30@osu.edu.ORCID 0000-0002-2193-9127
Nada Y KalaanyDivision of Endocrinology, Boston Children's Hospital, Boston, MA, USA. nada.kalaany@childrens.harvard.edu.ORCID 0000-0001-7489-1035

Funding

Role of Altered Nutrient Metabolism in Pancreatic CancerR01CA270110 · NCI · BOSTON CHILDREN'S HOSPITAL · PI Nada Y. Kalaany · 2022 to 2026
$2.6M
Mathematical modeling of metabolism rewiring in cancer eco-evolution and metastasis tropismR01CA266068 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Joao Xavier · 2023 to 2026
$2.3M
Metabolic determinants of metastatic heterogeneity: quantitative experiments and mathematical modelsF32CA260841 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI MATHUR, DEEPTI · 2021 to 2023
$223k
NCI NIH HHS F32 CA260841NCI NIH HHS R01 CA266068NCI NIH HHS R01 CA270110U.S. Department of Health & Human Services | National Institutes of Health (NIH) F32 CA260841U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01 CA266068U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01 CA270110
6 · The paper itself

Abstract

Cachexia or body wasting is a significant contributing factor to the morbidity and mortality of pancreatic cancer. Despite an unmet need, its metabolic underpinnings remain poorly understood. Here, we characterize a mouse model that recaptures the longitudinal progression of human cachexia during pancreatic cancer development. We profile the metabolomes of pre-, early- and late-stage cancer-associated cachexia in male and female pancreas, its interstitial fluid (IF), plasma, liver, adipose tissue and skeletal muscle. We find that each tissue has a unique metabolome and trajectory across stages and reveal a marked lipid enrichment in the tumor IF. Using mathematical modeling, we identify metabolites participating in cross-tissue networks and in vivo validate a lactate-glucose conversion. We find systemic metabolic changes prior to weight loss and use feature selection algorithms to identify early detection markers. Our study provides a resource for system-wide metabolic evolution of pancreatic cancer and associated cachexia, highlighting the potential for timely diagnostics and interventions.

Indexed as

CachexiaMetabolic Networks and PathwaysPancreatic NeoplasmsAdipose TissueAnimalsDisease Models, AnimalFemaleGlucoseHumansLactic AcidLiverMaleMetabolomeMetabolomicsMiceMice, Inbred C57BLGlucoseLactic Acid

Identifiers

PMID42897170
PMCPMC13680358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.